Europe’s medicines regulator said on Friday it had approved the production of Johnson & Johnson’s single-dose COVID-19 vaccine at an additional site in Italy, as it looks to speed up the supply of the shot in the European Union.
The site, located in Anagni, Italy, will help with vial filling and packaging of the vaccine developed by J&J’s Janssen unit, the European Medicines Agency (EMA) said, adding that U.S.-based Catalent is operating the site.
Last week, a spokesperson for the European Commission said J&J was expected to miss its EU supply target for the second quarter after millions of doses were banned for use in Europe over safety concerns…
Keep on reading: EU approves production line for J&J’s COVID-19 vaccine in Italy